Stay updated with breaking news from Quotient Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Launching a company based on knowledge that “the fundamental principle that most people hold to be true is off by a trillion” is a rare opportunity, said Jake Rubens, co-founder and president of Quotient Therapeutics Inc., a company that emerged from stealth this week, backed by two years of platform development and a $50 million investment from Flagship Pioneering.
IO Biotech, Quotient Sciences and Terumo Blood and Cell Technologies are among the key companies welcoming new colleagues.
/PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Gastroretentive Drug Delivery Systems...
/PRNewswire/ -- The "Global Pharmaceutical Contract Manufacturing Market - Forecast to 2030" report has been added to ResearchAndMarkets.com's offering....
Dublin, Nov. 14, 2023 (GLOBE NEWSWIRE) -- The